풍선판막성형술 기기 시장 보고서(2026년)
Balloon Valvuloplasty Device Global Market Report 2026
상품코드 : 1939323
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,707,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,694,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,682,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

풍선판막성형술 디바이스 시장 규모는 최근 현저한 성장을 달성하고 있습니다. 2025년 25억 7,000만 달러에서 2026년에는 27억 3,000만 달러로, CAGR 5.9%로 확대할 전망입니다. 지난 수년간의 성장에는 심장판막협착증 유병률 증가, 저침습적 심장 카테터 치료의 조기 도입, 표준적이고 순응도가 높은 풍선 기술 개발, 병원내 심장 카테터 검사실 확대, 소아 선천성 심장질환 치료 건수 증가 등이 주요 요인으로 꼽힙니다.

풍선판막성형술 디바이스 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 33억 5,000만 달러에 달하며, CAGR은 5.3%에 달할 전망입니다. 예측 기간 중 성장 요인으로는 대동맥판막 협착증 및 승모판막 협착증을 앓고 있는 고령 인구 증가, 고압 및 스코어링 풍선 장치에 대한 수요 증가, 외래 및 전문 클리닉에서 풍선판막성형술의 대중화, 비수술적 심장 치료 경로로의 전환 가속화, 풍선 재료 및 장치 설계의 지속적인 혁신 등이 있습니다. 혁신이 이루어지고 있습니다. 예측 기간 중 주요 동향으로는 최소침습적 판막 복원술에 대한 선호도 증가, 개흉수술의 대안으로 풍선판막 성형술의 채택 증가, 소아 및 성인 선천성 심장판막 질환에 대한 사용 확대, 전문 심장병 센터에서의 판막 확장술 확대, 환자 결과 개선 및 회복 기간 단축에 대한 관심 증가 등이 있습니다. 환자 예후 개선 및 회복기간 단축에 집중하고 있습니다.

최소침습 수술에 대한 선호도가 높아짐에 따라 향후 수년간 풍선판막성형술 기기 시장이 확대될 것으로 예측됩니다. 최소침습수술은 작은 절개나 자연 개구부를 통해 이루어지는 의료기술로, 기존 수술에 비해 조직 손상을 줄이고 빠른 회복을 가능하게 하는 의료기술입니다. 저침습 수술에 대한 수요 증가는 기존 수술 방식에 비해 회복 기간이 짧고, 합병증 위험이 낮으며, 수술 후 통증을 줄일 수 있다는 점 때문입니다. 풍선판막성형술 장치는 협착된 심장 판막을 확장하고 혈류를 개선하며 증상을 완화하기 위해 최소 침습 수술에 사용됩니다. 예를 들어 2024년 1월, 미국에 본사를 둔 로봇 수술 제품 제조업체인 인튜이티브 서지컬(Intuitive Surgical)은 2023년 4분기에 415대의 다빈치 수술 시스템을 설치했다고 보고했으며, 이는 2022년에 비해 12% 증가한 수치입니다. 따라서 최소 침습 수술에 대한 선호도가 높아지면서 풍선판막성형술 장치 시장 성장을 가속하고 있습니다.

풍선판막 성형술 장치 시장의 주요 기업은 경쟁력을 유지하기 위해 페이싱 가이드와이어와 같은 첨단 제품으로 혁신을 거듭하고 있습니다. 페이싱 가이드와이어는 풍선 카테터가 협착된 판막을 확장하는 동안 일시적인 심장 페이싱을 제공하여 심장의 안정성을 확보하기 위한 전용 기구입니다. 예를 들어 미국 의료기기 제조업체인 텔레플렉스(Teleflex)는 2023년 6월에 Watson 임시 페이싱 가이드와이어의 FDA 승인을 획득했습니다. 이 장치는 경피적 대동맥판막 치환술(TAVR) 및 풍선 대동맥판막 성형술(BAV) 시술에 특화되어 있으며, 유연한 원위부 피그테일 모양, 다중 전극, 안전성과 유효성을 향상시키는 양극성 설계가 특징입니다. 판막 전달 및 심실 페이싱을 지원하여 심실 천공과 같은 합병증 위험을 줄이고, 빠른 페이싱시 확실한 전기적 포착을 보장합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA
영문 목차

영문목차

A balloon valvuloplasty device is a medical instrument used in the treatment of heart valve stenosis. This procedure involves inserting a balloon into the narrowed valve and inflating it to widen the opening, thereby improving blood flow. It is a minimally invasive approach aimed at relieving symptoms such as chest pain and shortness of breath, ultimately enhancing cardiac function and improving patient quality of life.

The primary types of balloon valvuloplasty devices include standard balloons, cutting balloons, scoring balloons, high-pressure balloons, and low-pressure balloons. Standard balloon valvuloplasty devices are specifically designed to treat narrowed heart valves by expanding the valve opening through balloon inflation. This procedure is commonly performed in minimally invasive settings to alleviate symptoms associated with valve narrowing. These devices are used across pediatric and adult populations and are employed in various healthcare settings including hospitals, ambulatory surgical centers, specialty clinics, and others.

Tariffs are impacting the balloon valvuloplasty device market by increasing costs for catheter shafts, polymer balloon materials, guidewire components, and precision inflation systems sourced across international supply chains, resulting in higher manufacturing and import prices. The effect is more significant for high-pressure, scoring, and cutting balloon product categories, particularly in Asia-Pacific and European manufacturing hubs that rely heavily on imported device components. Hospitals, ambulatory surgical centers, and specialty cardiology clinics are experiencing elevated procurement costs and slower capital purchasing cycles due to tariff-related price pressures. However, tariffs are also encouraging localized device assembly, regional supplier development, and domestic production investments that may strengthen long-term supply resilience and manufacturing competitiveness.

The balloon valvuloplasty device market research report is one of a series of new reports from The Business Research Company that provides balloon valvuloplasty device market statistics, including balloon valvuloplasty device industry global market size, regional shares, competitors with a balloon valvuloplasty device market share, detailed balloon valvuloplasty device market segments, market trends and opportunities, and any further data you may need to thrive in the balloon valvuloplasty device industry. This balloon valvuloplasty device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The balloon valvuloplasty device market size has grown strongly in recent years. It will grow from $2.57 billion in 2025 to $2.73 billion in 2026 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to rise in prevalence of cardiac valve stenosis, early adoption of minimally invasive interventional cardiology procedures, development of standard and compliant balloon technologies, expansion of hospital-based cardiac catheterization labs, increasing treatment volumes in pediatric congenital heart cases.

The balloon valvuloplasty device market size is expected to see strong growth in the next few years. It will grow to $3.35 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to growing aging population with aortic and mitral valve stenosis, rising demand for high-pressure and scoring balloon devices, wider use of balloon valvuloplasty in ambulatory and specialty clinics, increasing shift toward non-surgical cardiac treatment pathways, ongoing innovation in balloon materials and device design. Major trends in the forecast period include increasing preference for minimally invasive valve repair procedures, rising adoption of balloon valvuloplasty as an alternative to open-heart surgery, growing utilization in pediatric and adult congenital heart valve disorders, expansion of valve dilation procedures in specialty cardiology centers, focus on improving patient outcomes and shorter recovery times.

The growing preference for minimally invasive procedures is anticipated to drive the expansion of the balloon valvuloplasty device market in the coming years. Minimally invasive procedures are medical techniques carried out through small incisions or natural body openings, which reduce tissue damage and support quicker recovery compared to conventional surgeries. The increasing demand for minimally invasive procedures is attributed to shorter recovery periods, a lower risk of complications, and reduced post-operative pain relative to traditional surgical approaches. Balloon valvuloplasty devices are utilized in minimally invasive procedures to dilate narrowed heart valves, enhance blood flow, and alleviate symptoms. For instance, in January 2024, Intuitive Surgical Inc., a US-based manufacturer of robotic surgical products, reported the placement of 415 da Vinci surgical systems in the fourth quarter of 2023, reflecting a 12% increase compared to 2022. Therefore, the rising preference for minimally invasive procedures is fueling the growth of the balloon valvuloplasty device market.

Key players in the balloon valvuloplasty device market are innovating with advanced products such as Pacing Guidewires to maintain competitiveness. Pacing guidewires are specialized tools used during procedures to provide temporary cardiac pacing, ensuring heart stability while balloon catheters dilate narrowed valves. For instance, Teleflex Incorporated, a US-based medical device company, recently received FDA clearance for the Wattson Temporary Pacing Guidewire in June 2023. This device is tailored for use in transcatheter aortic valve replacement (TAVR) and balloon aortic valvuloplasty (BAV) procedures, featuring a flexible distal pigtail shape, multiple electrodes, and bipolar design to enhance safety and efficacy. It supports valve delivery and ventricular pacing, reducing the risk of complications such as ventricular perforation and ensuring reliable electrical capture during rapid pacing.

In November 2023, OrbusNeich Medical Group Holdings Limited, headquartered in Hong Kong, acquired Eucatech AG for $2.3 million. This strategic acquisition enhances OrbusNeich's capabilities in providing comprehensive treatment solutions for cardiovascular diseases, bolstering its balloon valvuloplasty device offerings. Eucatech AG, based in Germany, is renowned for its innovative medical technology solutions including balloon valvuloplasty devices.

Major companies operating in the balloon valvuloplasty device market are Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, Edwards Lifesciences Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical Incorporated, Balton Sp z o o, Meril Life Sciences Pvt Ltd, JenaValve Technology Inc, Osypka Medical GmbH, Scitech Medical, Translumina GmbH, AndraTec GmbH, Palex Medical SA, Biosensors International Group Ltd, Hexacath, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, QT Vascular Ltd

North America was the largest region in the balloon valvuloplasty device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the balloon valvuloplasty device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the balloon valvuloplasty device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The balloon valvuloplasty device market consists of sales of scoring balloons, high-pressure balloons, and standard balloons. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Balloon Valvuloplasty Device Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses balloon valvuloplasty device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for balloon valvuloplasty device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The balloon valvuloplasty device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Balloon Valvuloplasty Device Market Characteristics

3. Balloon Valvuloplasty Device Market Supply Chain Analysis

4. Global Balloon Valvuloplasty Device Market Trends And Strategies

5. Balloon Valvuloplasty Device Market Analysis Of End Use Industries

6. Balloon Valvuloplasty Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Balloon Valvuloplasty Device Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Balloon Valvuloplasty Device Total Addressable Market (TAM) Analysis for the Market

9. Balloon Valvuloplasty Device Market Segmentation

10. Balloon Valvuloplasty Device Market Regional And Country Analysis

11. Asia-Pacific Balloon Valvuloplasty Device Market

12. China Balloon Valvuloplasty Device Market

13. India Balloon Valvuloplasty Device Market

14. Japan Balloon Valvuloplasty Device Market

15. Australia Balloon Valvuloplasty Device Market

16. Indonesia Balloon Valvuloplasty Device Market

17. South Korea Balloon Valvuloplasty Device Market

18. Taiwan Balloon Valvuloplasty Device Market

19. South East Asia Balloon Valvuloplasty Device Market

20. Western Europe Balloon Valvuloplasty Device Market

21. UK Balloon Valvuloplasty Device Market

22. Germany Balloon Valvuloplasty Device Market

23. France Balloon Valvuloplasty Device Market

24. Italy Balloon Valvuloplasty Device Market

25. Spain Balloon Valvuloplasty Device Market

26. Eastern Europe Balloon Valvuloplasty Device Market

27. Russia Balloon Valvuloplasty Device Market

28. North America Balloon Valvuloplasty Device Market

29. USA Balloon Valvuloplasty Device Market

30. Canada Balloon Valvuloplasty Device Market

31. South America Balloon Valvuloplasty Device Market

32. Brazil Balloon Valvuloplasty Device Market

33. Middle East Balloon Valvuloplasty Device Market

34. Africa Balloon Valvuloplasty Device Market

35. Balloon Valvuloplasty Device Market Regulatory and Investment Landscape

36. Balloon Valvuloplasty Device Market Competitive Landscape And Company Profiles

37. Balloon Valvuloplasty Device Market Other Major And Innovative Companies

38. Global Balloon Valvuloplasty Device Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Balloon Valvuloplasty Device Market

40. Balloon Valvuloplasty Device Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기